⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

IOVA

Iovance Biotherapeutics, Inc.

Healthcare · Biotechnology

14.09USD

-0.0500 (-0.35%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on IOVA.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 14.09
P/E—
Dvd Ind Yld0.0%
P/B8.67
P/S19.6
Curr EV/T12M EBITDA-23.6
Mkt Cap (USD)6.4B
Curr EV (USD)6.1B
2)

Per Share Data

EPS T12M-201.77
DPS—
Bk Val Per Sh1.63
Rev/Sh721.85
Cash/Sh0.66
Curr Shares Out453.0M
FCF/Sh-658.38
3)

Cash Flow Analysis

P/CF-24.2
Curr P/FCF-21.5
CF/NI0.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-81.3%
Eff Interest Rate-0.0%
4)

Growth Potential

Dil EPS 1Y Gr14.8%
Cap 1Y Gr-1.7%
BPS 1Y Gr-20.2%
R&D To Sales82.4%
Retention Rate100.0%
Rev 1Y Gr60.6%
FCF 1Y Gr7.6%
Assets 1Y Gr0.3%
5)

Profitability

EBITDA-0.3B
EBIT-0.3B
Operating Margin-92.7%
Pretax Margin-90.4%
Net Margin-89.1%
ROA-31.8%
ROE-40.4%
ROC-38.0%
Asset Turnover0.36
6)

Structure

Current Ratio4.35
Quick Ratio3.74
Debt/Assets5.0%
Debt/Com Eq6.3%
Net Debt/EBITDA0.23
Tot Debt/Capital5.9%
Gross Margin48.4%
EBIT/Int Exp45,146.7

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.